References
- Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 2008;7(11):1056–1066. doi:https://doi.org/10.1016/S1474-4422(08)70240-0.
- Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360(12):1226–1237. doi:https://doi.org/10.1056/NEJMra0804622.
- Kronenburg AJ, Braun KP, van der Zwan A, M Klijn CJ. Recent advances in moyamoya disease: pathophysiology and treatment. Curr Neurol Neurosci Rep. 2014;14. doi:https://doi.org/10.1007/s11910-013-0423-7.
- Mikami T, Suzuki H, Komatsu K, Mikuni N. Influence of inflammatory disease on the pathophysiology of moyamoya disease and quasi-moyamoya disease. Neurol Med Chir (Tokyo). 2019;59(10):1–10. doi:https://doi.org/10.2176/nmc.ra.2019-0059.
- Liu W, Morito D, Takashima S, et al. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. Meisel A, ed. PLoS One. 2011;6(7):e22542. doi:https://doi.org/10.1371/journal.pone.0022542.
- Bakri SJ, Siker D, Masaryk T, Luciano MG, Traboulsi EI. Ocular malformations, moyamoya disease, and midline cranial defects: a distinct syndrome. Am J Ophthalmol. 1999;127(3):356–357. doi:https://doi.org/10.1016/S0002-9394(98)00317-1.
- Sathyan S, Chackochan M. Morning glory disc anomaly and facial hemangiomas in a girl with moyamoya syndrome. Indian J Ophthalmol. 2018;66(11):1644–1646. doi:https://doi.org/10.4103/ijo.IJO_538_18.
- Kumar MA, Ganesh BA. CRAO in moyamoya disease. J Clin Diagn Res. 2013;7(3):545. /pmc/articles/PMC3616578/?report=abstract. Accessed July 1, 2020.
- Noda S, Hayasaka S, Setogawa T, Matsumoto S. Ocular symptoms of moyamoya disease. Am J Ophthalmol. 1987;103(6):812–816. doi:https://doi.org/10.1016/S0002-9394(14)74399-5.
- Lee JY, Choi YH, Cheon JE, et al. Delayed posterior circulation insufficiency in pediatric moyamoya disease. J Neurol. 2014;261(12):2305–2313. doi:https://doi.org/10.1007/s00415-014-7484-7.
- Seong HJ, Lee JH, Heo JH, Kim DS, Yong BK, Lee CS. Clinical significance of retinal vascular occlusion in moyamoya disease: case series and systematic review. Retina. 2021. Published ahead of time. doi:https://doi.org/10.1097/IAE.0000000000003181.
- Wang YY, Zhou KY, Ye Y. et al. Moyamoya disease associated with morning glory disc anomaly and other ophthalmic findings: a mini-review. Front Neurol. 2020;11:338. doi:https://doi.org/10.3389/fneur.2020.00338.
- Güçlü H, Gurlu VP, Ozal SA, Esgin H, Moyamoya A. Patient with bilateral consecutive branch retinal vein occlusion. Neuro-Ophthalmology. 2016;40(2):93–96. doi:https://doi.org/10.3109/01658107.2016.1148174.
- Albrecht P, Blasberg C, Lukas S, et al. Retinal pathology in idiopathic moyamoya angiopathy detected by optical coherence tomography. Neurology. 2015;85(6):521–527. doi:https://doi.org/10.1212/WNL.0000000000001832.
- De Carlo TE, Romano A, Waheed NK, Duker JS. A review of optical coherence tomography angiography (OCTA). Int J Retin Vitr. 2015;1(1):5. doi:https://doi.org/10.1186/s40942-015-0005-8.
- Lo J, Heisler M, Vanzan V, et al. Microvasculature segmentation and intercapillary area quantification of the deep vascular complex using transfer learning. Transl Vis Sci Technol. 2020;9(2):1–12. doi:https://doi.org/10.1167/tvst.9.2.38.
- Kang HS, Kim SK, Cho BK, Kim YY, Hwang YS, Wang KC. Single nucleotide polymorphisms of tissue inhibitor of metalloproteinase genes in familial moyamoya disease. Neurosurgery. 2006;58(6):1074–1079. doi:https://doi.org/10.1227/01.NEU.0000215854.66011.4F.
- Fukui M, Kono S, Sueishi K, Ikezaki K. Moyamoya disease. Neuropathology. 2000;20(SUPPL.):61–64. doi:https://doi.org/10.1046/j.1440-1789.2000.00300.x.